Detalles de la búsqueda
1.
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
N Engl J Med
; 375(25): 2423-2434, 2016 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27959713
2.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Lancet
; 389(10081): 1799-1808, 2017 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28325638
3.
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.
Lancet
; 388(10054): 1903-1911, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27585757
4.
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med
; 370(18): 1702-11, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24678955
5.
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes.
Am Heart J
; 186: 91-99, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454837
6.
Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation.
Europace
; 19(7): 1091-1095, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28641379
7.
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.
Eur Heart J
; 37(16): 1325-33, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26417057
8.
Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease.
Eur Heart J
; 37(25): 1993-2001, 2016 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27109584
9.
Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage.
Stroke
; 47(7): 1837-43, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27301947
10.
Pharmacological and emerging therapies in the treatment of chronic angina.
Lancet
; 386(9994): 691-701, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26334161
11.
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Am Heart J
; 177: 1-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297843
12.
Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
Europace
; 18(4): 492-500, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26443443
13.
Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes.
Am J Ther
; 23(6): e1876-e1889, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-25830867
14.
Population pharmacokinetics of ticagrelor in patients with acute coronary syndromes.
Int J Clin Pharmacol Ther
; 54(9): 666-74, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27191766
15.
Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.
Eur Heart J
; 36(29): 1901-12, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935875
16.
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Eur Heart J
; 36(46): 3268-75, 2015 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26371113
17.
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Circulation
; 129(6): 625-34, 2014 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-24226808
18.
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Circulation
; 129(3): 293-303, 2014 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24170388
19.
Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.
Am Heart J
; 169(6): 879-889.e7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26027627
20.
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
Am Heart J
; 169(4): 472-8.e5, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25819853